Serial testing for latent tuberculosis infection in transplant candidates: A retrospective review

Transplant Infectious Disease

Volumn 18, Issue 1, 2016, Pages 14-21

  Roth, P J ^a   Grim, S A ^b,c   Gallitano, S ^d   Adams, W ^e   Clark, N M ^b   Layden, J E ^b,e  

^a GREENVILLE HOSPITAL SYSTEM   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Latent tuberculosis infection diagnosis; Liver transplant; QuantiFERON; Renal transplant; Reproducibility; Serial IGRA testing

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LATENT TUBERCULOSIS; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; DEMOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; ILLINOIS; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PROCEDURES; REPRODUCIBILITY; RETROSPECTIVE STUDY;

ADULT; DEMOGRAPHY; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; ILLINOIS; INTERFERON-GAMMA RELEASE TESTS; KIDNEY TRANSPLANTATION; LATENT TUBERCULOSIS; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84958592710     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12489     Document Type: Article

References (24)

1. Horne DJ, Narita M, Spitters CL, Parimi S, Dodson S, Limaye AP. Challenging issues in tuberculosis in solid organ transplantation. Clin Iinfect Dis 2013; 57 (10): 1473-1482.
2. Subramanian AK, Morris MI, and American Society of Transplantation Infectious Diseases Community of Practice. Mycobacterium tuberculosis infections in solid organ transplantation. Am J Transplant 2013; 13 (Suppl 4): 68-76.
3. Milburn HJ. How should we treat tuberculosis in adult patients with chronic kidney disease? Key messages from the British Thoracic Society Guidelines. Pol Arch Med Wewn 2010; 120 (10): 417-422.
4. Manuel O, Humar A, Preiksaitis J, et al. Comparison of QuantiFERON-TB Gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007; 7 (12): 2797-2801.
5. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Rec Rep 2010; 59 (RR-5): 1-25.
6. Moon SM, Lee SO, Choi SH, et al. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation. Transpl Infect Dis 2013; 15 (1): 104-109.
7. Kim JS, Cho JH, Park GY, et al. Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation. Transplant Proc 2013; 45 (8): 2899-2902.
8. Ringshausen FC, Nienhaus A, Torres Costa J, et al. Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers. Clin Vaccine Immunol 2011; 18 (7): 1176-1182.
9. Gaur RL, Pai M, Banaei N. Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERON-TB Gold In-Tube assay. J Clin Microbiol 2013; 51 (11): 3521-3526.
10. Whitworth WC, Hamilton LR, Goodwin DJ, et al. Within-subject interlaboratory variability of QuantiFERON-TB Gold In-Tube tests. PLoS One 2012; 7 (9): e43790.
11. Zwerling A, Benedetti A, Cojocariu M, et al. Repeat IGRA testing in Canadian health workers: conversions or unexplained variability? PLoS One 2013; 8 (1): e54748.
12. Joshi M, Monson TP, Joshi A, Woods GL. IFN-gamma release assay conversions and reversions. Challenges with serial testing in U.S. health care workers. Ann Am Thorac Soc 2014; 11 (3): 296-302.
13. Ringshausen FC, Schablon A, Nienhaus A. Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review. J Occupat Med Toxicol (London) 2012; 7 (1): 6.
14. Slater ML, Welland G, Pai M, Parsonnet J, Banaei N. Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers. Am J Respir Crit J Med 2013; 188 (8): 1005-1010.
15. Cellestis. Quantiferon TB Gold (In-Tube Method) Package Insert. Food and Drug Administration, 2006: Doc No CA05990301A.
16. Ahmadinejad Z, Azmoudeh Ardalan F, Razzaqi M, Davoudi S, Jafarian A. QuantiFERON-TB Gold In-Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: a single-center study in an area endemic for TB. Transpl Infect Dis 2013; 15 (1): 90-95.
17. Theodoropoulos N, Lanternier F, Rassiwala J, et al. Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates: a single-center retrospective study. Transpl Infect Dis 2012; 14 (1): 1-8.
18. Yun JW, Chung HS, Koh WJ. Significant reduction in rate of indeterminate results of the QuantiFERON-TB Gold In-Tube test by shortening incubation delay. J Clin Microbiol 2014; 52 (1): 90-94.
19. Dorman SE, Belknap R, Graviss EA, et al. Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med 2014; 189 (1): 77-87.
20. Fong KS, Tomford JW, Teixeira L, et al. Challenges of interferon-gamma release assay conversions in serial testing of health-care workers in a TB control program. Chest 2012; 142 (1): 55-62.
21. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2012; 67 (1): 62-70.
22. Shu CC, Wu VC, Yang FJ, et al. Dynamic changes in positive interferon-gamma release assay in a dialysis population: an observational cohort study. J Infection 2013; 67 (6): 529-535.
23. Horsburgh CR Jr, Rubin EJ. Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med 2011; 364 (15): 1441-1448.
24. Sester M, van Leth F, Bruchfeld J, et al.; for the TBNET. Risk assessment of tuberculosis in immunocompromised patients - a TBNET study. Am J Respir Crit Care Med 2014; 190 (10): 1168-1176.